Efficacy and safety of cyclin-dependent kinase 4/6 inhibitor in patients with advanced breast cancer: A real-world experience.
Tzu-Rong PengJia-Hui ChenTa-Wei WuPublished in: Thoracic cancer (2023)
CDK4/6i administered in a real-world setting exhibits a similar survival benefit with the clinical trials.